Miles Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$351K Buy
10,756
+3,885
+57% +$152K 0.38% 73
2019
Q4
$311K Buy
6,871
+17
+0.2% +$711 0.25% 102
2019
Q3
$279K Buy
6,854
+26
+0.4% +$1.1K 0.23% 116
2019
Q2
$293K Buy
6,828
+806
+13% +$31K 0.24% 108
2019
Q1
$231K Sell
6,022
-731
-11% -$27.9K 0.2% 138
2018
Q4
$239K Buy
6,753
+84
+1% +$3.05K 0.24% 127
2018
Q3
$257K Buy
+6,669
New +$233K 0.21% 133

Other funds holding BSX

Miles Capital's BSX Position: Q1 2020 in Review

Miles Capital increased its Boston Scientific (BSX) stake by 57% in Q1 2020, buying an estimated $152K and bringing the position to 10,756 shares worth $351K. The position accounts for 0.38% of the portfolio, ranked #73.

Miles Capital first reported a position in BSX in Q3 2018 and has held it in 7 quarters since. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Miles Capital held 10,756 shares of Boston Scientific worth $351K as of Q1 2020.
  • Miles Capital bought 3,885 Boston Scientific shares in Q1 2020, an estimated $152K.
  • Boston Scientific made up 0.38% of Miles Capital's portfolio in Q1 2020, its #73 holding.
  • Miles Capital first reported a position in Boston Scientific in Q3 2018 and has held it in 7 quarters since.
  • 801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.